Mary Crowley Medical Research Center
Dallas, Texas 75201
We've found
5 trials
at this facility
Oncology Clinical Trial
Updated: 12/31/1969
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Squamous Cell Clinical Trial
Updated: 3/28/2008
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
Status: Enrolling,
Phase
III
Updated: 3/28/2008
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Malignant Solid Tumor Clinical Trial
Updated: 12/31/1969
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Carcinoma, Squamous Cell Clinical Trial
Updated: 9/10/2007
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone
Status: Enrolling,
Phase
III
Updated: 9/10/2007
Click here to add this to my saved trials